Recursion Pharmaceuticals shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Recursion Pharmaceuticals (RXRX) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Recursion Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Recursion Pharmaceuticals held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Recursion Pharmaceuticals by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $2.2M | 227k | 9.86 |
| 2023-09-30 | $1.6M | 212k | 7.65 |
| 2023-06-30 | $769k | 115k | 6.67 |
| 2023-03-31 | $769k | 115k | 6.67 |
| 2022-12-31 | $824k | 107k | 7.71 |
| 2022-09-30 | $818k | 77k | 10.64 |
| 2022-06-30 | $419k | 52k | 8.14 |
| 2022-03-31 | $345k | 48k | 7.16 |
| 2021-12-31 | $607k | 36k | 17.13 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas